LiliMe的个人主页 - 老虎社区

LiliMe

LiliMe

暂无个人介绍

IP属地：未知

34关注

6粉丝

0主题

0勋章

2021-12-29

👌

S&P 500 Ends Lower after Four-Day Rally to Record High

2021-12-19

Interesting

3 Stocks That Could Be Worth More Than Apple by 2035

2021-12-10

👍

Singapore Stock Market Tipped To Head South Again On Friday

2021-12-10

👍

抱歉，原内容已删除

2021-12-03

Ok

5 Stocks To Watch For December 3, 2021

2021-12-02

Thanks

10 Biggest Price Target Changes For Wednesday

2021-12-02

Thanks

抱歉，原内容已删除

2021-12-01

👍

5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market

2021-12-01

👍

Gold and silver stocks jumped in morning trading

2021-11-29

👍

Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week

2021-11-28

👌

Prediction: These 2 Stocks Will Soar in 2022

2021-11-24

Happy Thanksgiving!

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4099622722860440","uuid":"4099622722860440","gmtCreate":1636542016438,"gmtModify":1636545120034,"name":"LiliMe","pinyin":"lilime","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":34,"tweetSize":12,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.56%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":696418072,"gmtCreate":1640745844616,"gmtModify":1640745844757,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696418072","repostId":"1186633322","repostType":4,"repost":{"id":"1186633322","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640732718,"share":"https://www.laohu8.com/m/news/1186633322?lang=&edition=full","pubTime":"2021-12-29 07:05","market":"us","language":"en","title":"S&P 500 Ends Lower after Four-Day Rally to Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1186633322","media":"Reuters","summary":"Dec 28  - The S&P 500closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.The Centers for Disease Control and Prevention  on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.The update follows approvals for new pills and more vaccines to fight COVID-19. It hel","content":"<p>Dec 28 (Reuters) - The S&amp;P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.</p>\n<p>The Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.</p>\n<p>The update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc(AAPL.O)shutting its <a href=\"https://laohu8.com/S/NWY\">New York</a> stores due to surging cases, and put U.S. stocks on pace for monthly gains.</p>\n<p>\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in <a href=\"https://laohu8.com/S/NYRT\">New York</a>.</p>\n<p>Seven&nbsp;of the 11 major S&amp;P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and <a href=\"https://laohu8.com/S/JCS\">Communications</a> Services(.SPLRCL)led declines.</p>\n<p>The Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&amp;P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.</p>\n<p>In company news, <a href=\"https://laohu8.com/S/BA\">Boeing</a> Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the aircraft and loss of all 189 people on board.</p>\n<p>Markets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&amp;P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.</p>\n<p>\"<a href=\"https://laohu8.com/S/ISBC\">Investors</a> are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.</p>\n<p>The Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5</p>\n<p>Volume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 Ends Lower after Four-Day Rally to Record High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 Ends Lower after Four-Day Rally to Record High\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-29 07:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 28 (Reuters) - The S&amp;P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.</p>\n<p>The Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.</p>\n<p>The update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc(AAPL.O)shutting its <a href=\"https://laohu8.com/S/NWY\">New York</a> stores due to surging cases, and put U.S. stocks on pace for monthly gains.</p>\n<p>\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in <a href=\"https://laohu8.com/S/NYRT\">New York</a>.</p>\n<p>Seven&nbsp;of the 11 major S&amp;P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and <a href=\"https://laohu8.com/S/JCS\">Communications</a> Services(.SPLRCL)led declines.</p>\n<p>The Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&amp;P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.</p>\n<p>In company news, <a href=\"https://laohu8.com/S/BA\">Boeing</a> Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the aircraft and loss of all 189 people on board.</p>\n<p>Markets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&amp;P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.</p>\n<p>\"<a href=\"https://laohu8.com/S/ISBC\">Investors</a> are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.</p>\n<p>The Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5</p>\n<p>Volume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","UPRO":"三倍做多标普500ETF","SSO":"两倍做多标普500ETF","SDS":"两倍做空标普500ETF","IVV":"标普500指数ETF","SH":"标普500反向ETF","BK4534":"瑞士信贷持仓","OEF":"标普100指数ETF-iShares",".SPX":"S&P 500 Index","SPY":"标普500ETF","SPXU":"三倍做空标普500ETF","BK4504":"桥水持仓","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","OEX":"标普100"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186633322","content_text":"Dec 28 (Reuters) - The S&P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.\nThe Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.\nThe update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and Apple Inc(AAPL.O)shutting its New York stores due to surging cases, and put U.S. stocks on pace for monthly gains.\n\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in New York.\nSeven of the 11 major S&P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and Communications Services(.SPLRCL)led declines.\nThe Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the Nasdaq Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.\nIn company news, Boeing Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of one of the aircraft and loss of all 189 people on board.\nMarkets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.\n\"Investors are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.\nThe Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5\nVolume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.\nThe S&P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699731988,"gmtCreate":1639890328741,"gmtModify":1639890328871,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699731988","repostId":"2192035909","repostType":4,"repost":{"id":"2192035909","kind":"highlight","pubTimestamp":1639886839,"share":"https://www.laohu8.com/m/news/2192035909?lang=&edition=full","pubTime":"2021-12-19 12:07","market":"us","language":"en","title":"3 Stocks That Could Be Worth More Than Apple by 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2192035909","media":"Motley Fool","summary":"These companies could eclipse the iPhone maker's market cap in the long run.","content":"<p><a href=\"https://laohu8.com/S/AAPL\"><b>Apple</b></a> is currently the world's most valuable&nbsp;company with a market capitalization of $2.82 trillion. That isn't surprising as the tech titan is a dominant player in the smartphone market and has ancillary products and services to drive growth.</p>\n<p>The tech giant generated a whopping $365.8 billion in revenue in fiscal 2021, an increase of 33% over the prior year. The fact that Apple is growing at an eye-popping pace despite being a mega-cap company is impressive, but it's not surprising as its products and services are in great demand. More importantly, Apple isn't resting on its laurels and is looking to push the envelope by seizing emerging tech trends and moving into new markets.</p>\n<p>As such, Apple is pulling several strings to ensure that it remains the world's most valuable company for a long time to come. However, the likes of <a href=\"https://laohu8.com/S/NVDA\"><b>Nvidia</b> </a>, <a href=\"https://laohu8.com/S/ASML\"><b>ASML Holding</b> </a>, and <a href=\"https://laohu8.com/S/AMZN\"><b>Amazon</b> </a> could become more valuable than Apple by 2035, thanks to the fast-growing markets they operate in. Let's see why that may be the case.</p>\n<p>1. <a href=\"https://laohu8.com/S/NVDA\"><b>Nvidia</b> </a></p>\n<p>Nvidia has a market cap&nbsp;of $707 billion. It is worth noting that the graphics card specialist's market cap has grown at a much faster pace than that of Apple's in the past decade.</p>\n<p><img src=\"https://static.tigerbbs.com/014d345dc7df797b4ee5e9f0e2288910\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>NVDA data by YCharts</p>\n<p>Nvidia shares have stepped on the gas since 2016. They have gone supersonic in the past couple of years as it has become clear that its graphics cards play an important role in powering several applications ranging from gaming consoles to personal computers to data centers and autonomous vehicles. The massive demand for Nvidia's graphics cards is evident from the company's recent results.</p>\n<p>The company has generated&nbsp;$19.3 billion in revenue in the first nine months of fiscal 2022, a jump of 65% over the prior-year period. Its adjusted earnings have increased 81% in the first nine months of the year to $3.12 per share. This terrific growth has been driven by two key catalysts -- gaming and data centers.</p>\n<p>Nvidia absolutely dominates these two markets. The company has an 83% share&nbsp;of discrete graphics cards that power gaming PCs, while its share of the booming data center accelerator market reportedly stood at 80.6% a&nbsp;year ago. The good part is that both these markets are expected to add billions of dollars of revenue in the future. The GPU (graphics processing unit) market, for instance, is expected to clock a 33% annual growth rate through 2028 and hit $246 billion in value, according to a third-party estimate.</p>\n<p>The use of GPUs as data-center accelerators is increasing&nbsp;at 42% a year, a pace that's expected to continue through 2027. Throw in budding catalysts such as the omniverse and self-driving cars, and it is easy to see why Nvidia's earnings are expected to increase&nbsp;at an annual pace of close to 40% for the next five years. That's way higher than Apple's projected earnings growth rate&nbsp;of 15% over the same period, which further indicates why Nvidia could be a solid candidate to overtake Apple's market cap in the next 15 years.</p>\n<p>2. <a href=\"https://laohu8.com/S/ASML\"><b>ASML Holding</b> </a></p>\n<p>Apple was unable to make enough iPhones and iPads last quarter due to supply chain constraints arising out of the global chip shortage, and that cost&nbsp;the tech giant $6 billion in revenue. ASML is <a href=\"https://laohu8.com/S/AONE.U\">one</a> company that could help get more chips into the hands of Apple and others that are suffering from a lack of chips on account of the semiconductor shortage.</p>\n<p>This is probably one of the reasons why ASML stock has been a top performer in 2021 and has outpaced Apple's gains by a significant margin this year.</p>\n<p><img src=\"https://static.tigerbbs.com/6aab71d6833e529191334d42cac0289f\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>AAPL data by YCharts</p>\n<p>It won't be surprising to see this trend continue as the demand for ASML's machines that help foundries make chips has gone through the roof. Net bookings for ASML's machines increased&nbsp;to 6.2 billion euros in the third quarter of 2021, more than double as compared to net bookings of 2.87 billion euros in the year-ago period.</p>\n<p>The Dutch giant reported a 32% increase in revenue during the quarter to 5.24 billion euros. The fact that ASML's bookings increased at a faster pace than the actual revenue indicates that it can sustain its impressive top-line growth by fulfilling more of its orders and turning the backlog into actual sales. The company is on track to finish 2021 with 35% revenue growth, and Wall Street's estimates suggest that it can keep growing at such an impressive pace for a long time to come.</p>\n<p>Venture capital firm Air Street Capital estimates that ASML could hit $500 billion in market cap next year, which would be a huge jump over its current market cap of $311 billion. What's more, ASML's earnings are expected&nbsp;to grow at almost 30% a year for the next five years, which is double Apple's projected growth.</p>\n<p>ASML seems to be in a solid position to deliver on Wall Street's forecasts as the semiconductor market is expected to generate&nbsp;$1 trillion in revenue by 2030, a big jump from 2018 levels of $466 billion. Foundries would need to spend more money on equipment to cater to the huge demand, and this could supercharge ASML in the long run as it is the biggest player in the market for photolithography machines.</p>\n<p>3. <a href=\"https://laohu8.com/S/AMZN\"><b>Amazon</b> </a></p>\n<p>Amazon is yet another stock that has easily outpaced Apple's gains in the past decade.</p>\n<p><img src=\"https://static.tigerbbs.com/e823ea95df1ad4c8e9cc5d870dc478b7\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>AAPL data by YCharts</p>\n<p>Amazon's focus on diversifying itself from a vanilla e-commerce company into a leading provider of cloud computing services, video streaming, music streaming, and on dominating the markets it operates in has helped the company grow at an eye-popping pace and hit a market cap&nbsp;of $1.7 trillion. This tech stock is expected to keep up its tremendous growth in the coming years, with earnings expected&nbsp;to increase at a compound annual growth rate of 36%.</p>\n<p>Again, this is much higher than Apple's projected growth rate. That's because Amazon is on track to take advantage of several fast-growing end markets. For instance, the company's Amazon Web Services (AWS) cloud computing division holds&nbsp;a 32% share of the $150 billion cloud infrastructure market. Third-party estimates peg the size of the global cloud computing market&nbsp;at $927 billion by 2027, which should ensure a high pace of growth in the AWS segment.</p>\n<p>Amazon's AWS revenue had jumped&nbsp;39% year over year in the third quarter to $16 billion, outpacing the growth in the e-commerce segments. Meanwhile, Amazon holds 40% of the U.S. e-commerce market that's expected to hit $8 trillion in revenue by 2030. All this indicates that the company's top line could jump big time in the coming years compared to its trailing-12-month revenue&nbsp;of $458 billion.</p>\n<p>As such, Amazon stock could continue to be a better growth pick than Apple in the next decade and beyond. It may eventually eclipse the iPhone maker's market cap in the long run, considering its much faster pace of growth.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks That Could Be Worth More Than Apple by 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks That Could Be Worth More Than Apple by 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 12:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/18/stocks-that-could-be-worth-more-than-apple-2035/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple is currently the world's most valuable company with a market capitalization of $2.82 trillion. That isn't surprising as the tech titan is a dominant player in the smartphone market and has ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/18/stocks-that-could-be-worth-more-than-apple-2035/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4566":"资本集团","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4553":"喜马拉雅资本持仓","BK4170":"电脑硬件、储存设备及电脑周边","BK4550":"红杉资本持仓","BK4559":"巴菲特持仓","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4501":"段永平概念","AAPL":"苹果","BK4527":"明星科技股","BK4505":"高瓴资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.fool.com/investing/2021/12/18/stocks-that-could-be-worth-more-than-apple-2035/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192035909","content_text":"Apple is currently the world's most valuable company with a market capitalization of $2.82 trillion. That isn't surprising as the tech titan is a dominant player in the smartphone market and has ancillary products and services to drive growth.\nThe tech giant generated a whopping $365.8 billion in revenue in fiscal 2021, an increase of 33% over the prior year. The fact that Apple is growing at an eye-popping pace despite being a mega-cap company is impressive, but it's not surprising as its products and services are in great demand. More importantly, Apple isn't resting on its laurels and is looking to push the envelope by seizing emerging tech trends and moving into new markets.\nAs such, Apple is pulling several strings to ensure that it remains the world's most valuable company for a long time to come. However, the likes of Nvidia , ASML Holding , and Amazon  could become more valuable than Apple by 2035, thanks to the fast-growing markets they operate in. Let's see why that may be the case.\n1. Nvidia \nNvidia has a market cap of $707 billion. It is worth noting that the graphics card specialist's market cap has grown at a much faster pace than that of Apple's in the past decade.\n\nNVDA data by YCharts\nNvidia shares have stepped on the gas since 2016. They have gone supersonic in the past couple of years as it has become clear that its graphics cards play an important role in powering several applications ranging from gaming consoles to personal computers to data centers and autonomous vehicles. The massive demand for Nvidia's graphics cards is evident from the company's recent results.\nThe company has generated $19.3 billion in revenue in the first nine months of fiscal 2022, a jump of 65% over the prior-year period. Its adjusted earnings have increased 81% in the first nine months of the year to $3.12 per share. This terrific growth has been driven by two key catalysts -- gaming and data centers.\nNvidia absolutely dominates these two markets. The company has an 83% share of discrete graphics cards that power gaming PCs, while its share of the booming data center accelerator market reportedly stood at 80.6% a year ago. The good part is that both these markets are expected to add billions of dollars of revenue in the future. The GPU (graphics processing unit) market, for instance, is expected to clock a 33% annual growth rate through 2028 and hit $246 billion in value, according to a third-party estimate.\nThe use of GPUs as data-center accelerators is increasing at 42% a year, a pace that's expected to continue through 2027. Throw in budding catalysts such as the omniverse and self-driving cars, and it is easy to see why Nvidia's earnings are expected to increase at an annual pace of close to 40% for the next five years. That's way higher than Apple's projected earnings growth rate of 15% over the same period, which further indicates why Nvidia could be a solid candidate to overtake Apple's market cap in the next 15 years.\n2. ASML Holding \nApple was unable to make enough iPhones and iPads last quarter due to supply chain constraints arising out of the global chip shortage, and that cost the tech giant $6 billion in revenue. ASML is one company that could help get more chips into the hands of Apple and others that are suffering from a lack of chips on account of the semiconductor shortage.\nThis is probably one of the reasons why ASML stock has been a top performer in 2021 and has outpaced Apple's gains by a significant margin this year.\n\nAAPL data by YCharts\nIt won't be surprising to see this trend continue as the demand for ASML's machines that help foundries make chips has gone through the roof. Net bookings for ASML's machines increased to 6.2 billion euros in the third quarter of 2021, more than double as compared to net bookings of 2.87 billion euros in the year-ago period.\nThe Dutch giant reported a 32% increase in revenue during the quarter to 5.24 billion euros. The fact that ASML's bookings increased at a faster pace than the actual revenue indicates that it can sustain its impressive top-line growth by fulfilling more of its orders and turning the backlog into actual sales. The company is on track to finish 2021 with 35% revenue growth, and Wall Street's estimates suggest that it can keep growing at such an impressive pace for a long time to come.\nVenture capital firm Air Street Capital estimates that ASML could hit $500 billion in market cap next year, which would be a huge jump over its current market cap of $311 billion. What's more, ASML's earnings are expected to grow at almost 30% a year for the next five years, which is double Apple's projected growth.\nASML seems to be in a solid position to deliver on Wall Street's forecasts as the semiconductor market is expected to generate $1 trillion in revenue by 2030, a big jump from 2018 levels of $466 billion. Foundries would need to spend more money on equipment to cater to the huge demand, and this could supercharge ASML in the long run as it is the biggest player in the market for photolithography machines.\n3. Amazon \nAmazon is yet another stock that has easily outpaced Apple's gains in the past decade.\n\nAAPL data by YCharts\nAmazon's focus on diversifying itself from a vanilla e-commerce company into a leading provider of cloud computing services, video streaming, music streaming, and on dominating the markets it operates in has helped the company grow at an eye-popping pace and hit a market cap of $1.7 trillion. This tech stock is expected to keep up its tremendous growth in the coming years, with earnings expected to increase at a compound annual growth rate of 36%.\nAgain, this is much higher than Apple's projected growth rate. That's because Amazon is on track to take advantage of several fast-growing end markets. For instance, the company's Amazon Web Services (AWS) cloud computing division holds a 32% share of the $150 billion cloud infrastructure market. Third-party estimates peg the size of the global cloud computing market at $927 billion by 2027, which should ensure a high pace of growth in the AWS segment.\nAmazon's AWS revenue had jumped 39% year over year in the third quarter to $16 billion, outpacing the growth in the e-commerce segments. Meanwhile, Amazon holds 40% of the U.S. e-commerce market that's expected to hit $8 trillion in revenue by 2030. All this indicates that the company's top line could jump big time in the coming years compared to its trailing-12-month revenue of $458 billion.\nAs such, Amazon stock could continue to be a better growth pick than Apple in the next decade and beyond. It may eventually eclipse the iPhone maker's market cap in the long run, considering its much faster pace of growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605979131,"gmtCreate":1639106306823,"gmtModify":1639106602213,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605979131","repostId":"1144028780","repostType":4,"repost":{"id":"1144028780","kind":"news","pubTimestamp":1639094962,"share":"https://www.laohu8.com/m/news/1144028780?lang=&edition=full","pubTime":"2021-12-10 08:09","market":"sg","language":"en","title":"Singapore Stock Market Tipped To Head South Again On Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1144028780","media":"RTTNews","summary":"The Singapore stock market bounced higher again on Thursday, one session after halting the three-day","content":"<p></p>\n<p></p>\n<p>The Singapore stock market bounced higher again on Thursday, one session after halting the three-day winning streak in which it had collected almost 45 points or 1.4 percent. The Straits Times Index now sits just above the 3,140-point plateau although it's likely to see renewed selling pressure on Friday.</p>\n<p></p>\n<p>The global forecast for the Asian markets is negative, with profit taking expected particularly among the oil and technology stocks. The European and U.S. markets finished lower and the Asian markets figure to open in similar fashion.</p>\n<p></p>\n<p>The STI finished modestly higher on Thursday following gains from the industrials and a mixed picture from the financial shares.</p>\n<p></p>\n<p>For the day, the index gained 12.68 points or 0.41 percent to finish at 3,142.45 after trading between 3,134.40 and 3,152.34. Volume was 1.3 billion shares worth 867.3 million Singapore dollars. There were 280 gainers and 156 decliners.</p>\n<p></p>\n<p>Among the actives, City Developments soared 1.30 percent, while Comfort DelGro advanced 0.71 percent, Dairy Farm International dropped 0.99 percent, DBS Group dipped 0.13 percent, Genting Singapore added 0.64 percent, Keppel Corp was up 0.38 percent, Mapletree Commercial Trust rallied 0.98 percent, Mapletree Logistics Trust gained 0.53 percent, Oversea-Chinese Banking Corporation sank 0.44 percent, SATS accelerated 1.03 percent, SembCorp Industries rose 0.50 percent, Singapore Airlines spiked 1.20 percent, Singapore Exchange perked 0.75 percent, Singapore Press Holdings jumped 0.86 percent, Singapore Technologies Engineering climbed 0.80 percent, United Overseas Bank collected 0.19 percent, Wilmar International surged 1.44 percent, Yangzijiang Shipbuilding gathered 0.77 percent and CapitaLand Integrated Commercial Trust, Ascendas REIT, SingTel and Thai Beverage were unchanged.</p>\n<p></p>\n<p>The lead from Wall Street is soft as the major averages opened lower on Thursday. The Dow moved into the green for a time before ending flat, while the NASDAQ and S&amp;P 500 finished solidly in the red.</p>\n<p></p>\n<p>The Dow eased 0.06 points to finish at 25,754.69, while the NASDAQ tumbled 269.62 points or 1.71 percent to close at 15,517.37 and the S&amp;P 500 dropped 33.76 points or 0.72 percent to end at 4,667.45.</p>\n<p></p>\n<p>The pullback on Wall Street came as traders cashed in on the recent strength in the markets, which saw stocks recover strongly from the post-Thanksgiving sell-off triggered by the detection of the Omicron variant of the coronavirus.</p>\n<p></p>\n<p>With concerns about the impact of the Omicron variant easing, traders are now looking ahead to next week's Federal Reserve's monetary policy announcement. Reports suggest the Fed could decide to double the pace of tapering its asset purchase program to $30 billion per month.</p>\n<p></p>\n<p>In economic news, the Labor Department said first-time jobless claims pulled back by much more than expected last week.</p>\n<p></p>\n<p>Crude oil settled lower Thursday amid concerns about the outlook for energy demand following several countries imposing fresh restrictions on movements to curb the spread of Omicron. West Texas Intermediate Crude oil futures for January sank $1.42 or 2 percent at $70.94 a barrel.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Stock Market Tipped To Head South Again On Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Stock Market Tipped To Head South Again On Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 08:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.rttnews.com/3248262/singapore-stock-market-tipped-to-head-south-again-on-friday.aspx?type=acom><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market bounced higher again on Thursday, one session after halting the three-day winning streak in which it had collected almost 45 points or 1.4 percent. The Straits Times Index ...</p>\n\n<a href=\"https://www.rttnews.com/3248262/singapore-stock-market-tipped-to-head-south-again-on-friday.aspx?type=acom\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3248262/singapore-stock-market-tipped-to-head-south-again-on-friday.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144028780","content_text":"The Singapore stock market bounced higher again on Thursday, one session after halting the three-day winning streak in which it had collected almost 45 points or 1.4 percent. The Straits Times Index now sits just above the 3,140-point plateau although it's likely to see renewed selling pressure on Friday.\n\nThe global forecast for the Asian markets is negative, with profit taking expected particularly among the oil and technology stocks. The European and U.S. markets finished lower and the Asian markets figure to open in similar fashion.\n\nThe STI finished modestly higher on Thursday following gains from the industrials and a mixed picture from the financial shares.\n\nFor the day, the index gained 12.68 points or 0.41 percent to finish at 3,142.45 after trading between 3,134.40 and 3,152.34. Volume was 1.3 billion shares worth 867.3 million Singapore dollars. There were 280 gainers and 156 decliners.\n\nAmong the actives, City Developments soared 1.30 percent, while Comfort DelGro advanced 0.71 percent, Dairy Farm International dropped 0.99 percent, DBS Group dipped 0.13 percent, Genting Singapore added 0.64 percent, Keppel Corp was up 0.38 percent, Mapletree Commercial Trust rallied 0.98 percent, Mapletree Logistics Trust gained 0.53 percent, Oversea-Chinese Banking Corporation sank 0.44 percent, SATS accelerated 1.03 percent, SembCorp Industries rose 0.50 percent, Singapore Airlines spiked 1.20 percent, Singapore Exchange perked 0.75 percent, Singapore Press Holdings jumped 0.86 percent, Singapore Technologies Engineering climbed 0.80 percent, United Overseas Bank collected 0.19 percent, Wilmar International surged 1.44 percent, Yangzijiang Shipbuilding gathered 0.77 percent and CapitaLand Integrated Commercial Trust, Ascendas REIT, SingTel and Thai Beverage were unchanged.\n\nThe lead from Wall Street is soft as the major averages opened lower on Thursday. The Dow moved into the green for a time before ending flat, while the NASDAQ and S&P 500 finished solidly in the red.\n\nThe Dow eased 0.06 points to finish at 25,754.69, while the NASDAQ tumbled 269.62 points or 1.71 percent to close at 15,517.37 and the S&P 500 dropped 33.76 points or 0.72 percent to end at 4,667.45.\n\nThe pullback on Wall Street came as traders cashed in on the recent strength in the markets, which saw stocks recover strongly from the post-Thanksgiving sell-off triggered by the detection of the Omicron variant of the coronavirus.\n\nWith concerns about the impact of the Omicron variant easing, traders are now looking ahead to next week's Federal Reserve's monetary policy announcement. Reports suggest the Fed could decide to double the pace of tapering its asset purchase program to $30 billion per month.\n\nIn economic news, the Labor Department said first-time jobless claims pulled back by much more than expected last week.\n\nCrude oil settled lower Thursday amid concerns about the outlook for energy demand following several countries imposing fresh restrictions on movements to curb the spread of Omicron. West Texas Intermediate Crude oil futures for January sank $1.42 or 2 percent at $70.94 a barrel.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1042,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605979970,"gmtCreate":1639106274084,"gmtModify":1639106601602,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605979970","repostId":"1120676537","repostType":4,"isVote":1,"tweetType":1,"viewCount":921,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601261439,"gmtCreate":1638536050441,"gmtModify":1638536050529,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601261439","repostId":"2188540330","repostType":4,"repost":{"id":"2188540330","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1638524158,"share":"https://www.laohu8.com/m/news/2188540330?lang=&edition=full","pubTime":"2021-12-03 17:35","market":"us","language":"en","title":"5 Stocks To Watch For December 3, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2188540330","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\tWall Street expects  Big Lots, Inc.  (NYSE: BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading.\n","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Big Lots, Inc.</b>&nbsp;(NYSE:BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading&nbsp;Thursday.</li>\n <li><b>DiDi Global Inc.</b>&nbsp;(NYSE:DIDI) said that its board of directors had authorized the company to initiate procedures to delist the company’s shares from the New York Stock Exchange. The company, however, announced plans to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange. DiDi Global shares jumped 9.5% to $8.54 in premarket trading&nbsp;Friday.</li>\n <li>Analysts are expecting&nbsp;<b>Hibbett, Inc.</b>&nbsp;(NASDAQ:HIBB) to have earned $1.57 per share on revenue of $360.63 million for the latest quarter. The company will release earnings before the markets open. Hibbett shares rose 0.3% to $72.35 in after-hours trading&nbsp;Thursday.</li>\n</ul>\n<ul>\n <li><b>Tesla Inc</b> (NASDAQ:TSLA) Elon Musk sold another 934,091 shares worth around $1.01 billion in order to fulfill his tax obligations, as per filings made with the U.S. Securities And Exchange Commission Thursday. Musk also exercised options to purchase 2.1 million shares of the automaker at $6.24, as per one of the filings. In late November, the company’s CEO had sold $1 billion worth of Tesla shares. Tesla shares rose 0.3% to $1,088 in premarket tradingFriday.</li>\n <li><b>Ulta Beauty, Inc.</b> (NASDAQ:ULTA) reported better-than-expected results for its third quarter and raised its FY21 forecast. Ulta Beauty shares climbed 5.2% to $403.50 in the after-hours trading Thursday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For December 3, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For December 3, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-03 17:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Big Lots, Inc.</b>&nbsp;(NYSE:BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading&nbsp;Thursday.</li>\n <li><b>DiDi Global Inc.</b>&nbsp;(NYSE:DIDI) said that its board of directors had authorized the company to initiate procedures to delist the company’s shares from the New York Stock Exchange. The company, however, announced plans to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange. DiDi Global shares jumped 9.5% to $8.54 in premarket trading&nbsp;Friday.</li>\n <li>Analysts are expecting&nbsp;<b>Hibbett, Inc.</b>&nbsp;(NASDAQ:HIBB) to have earned $1.57 per share on revenue of $360.63 million for the latest quarter. The company will release earnings before the markets open. Hibbett shares rose 0.3% to $72.35 in after-hours trading&nbsp;Thursday.</li>\n</ul>\n<ul>\n <li><b>Tesla Inc</b> (NASDAQ:TSLA) Elon Musk sold another 934,091 shares worth around $1.01 billion in order to fulfill his tax obligations, as per filings made with the U.S. Securities And Exchange Commission Thursday. Musk also exercised options to purchase 2.1 million shares of the automaker at $6.24, as per one of the filings. In late November, the company’s CEO had sold $1 billion worth of Tesla shares. Tesla shares rose 0.3% to $1,088 in premarket tradingFriday.</li>\n <li><b>Ulta Beauty, Inc.</b> (NASDAQ:ULTA) reported better-than-expected results for its third quarter and raised its FY21 forecast. Ulta Beauty shares climbed 5.2% to $403.50 in the after-hours trading Thursday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4561":"索罗斯持仓","BK4505":"高瓴资本持仓","TSLA":"特斯拉","BK4539":"次新股","CEO":"中海油","DIDI":"滴滴(已退市)","BIG":"必乐透","ULTA":"Ulta美容","BK4526":"热门中概股","BK4200":"专卖店","BK4114":"综合货品商店","HIBB":"希贝特体育","BK4535":"淡马锡持仓","BK4022":"陆运"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188540330","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Big Lots, Inc. (NYSE:BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading Thursday.\nDiDi Global Inc. (NYSE:DIDI) said that its board of directors had authorized the company to initiate procedures to delist the company’s shares from the New York Stock Exchange. The company, however, announced plans to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange. DiDi Global shares jumped 9.5% to $8.54 in premarket trading Friday.\nAnalysts are expecting Hibbett, Inc. (NASDAQ:HIBB) to have earned $1.57 per share on revenue of $360.63 million for the latest quarter. The company will release earnings before the markets open. Hibbett shares rose 0.3% to $72.35 in after-hours trading Thursday.\n\n\nTesla Inc (NASDAQ:TSLA) Elon Musk sold another 934,091 shares worth around $1.01 billion in order to fulfill his tax obligations, as per filings made with the U.S. Securities And Exchange Commission Thursday. Musk also exercised options to purchase 2.1 million shares of the automaker at $6.24, as per one of the filings. In late November, the company’s CEO had sold $1 billion worth of Tesla shares. Tesla shares rose 0.3% to $1,088 in premarket tradingFriday.\nUlta Beauty, Inc. (NASDAQ:ULTA) reported better-than-expected results for its third quarter and raised its FY21 forecast. Ulta Beauty shares climbed 5.2% to $403.50 in the after-hours trading Thursday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1796,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603497233,"gmtCreate":1638437025726,"gmtModify":1638437670837,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603497233","repostId":"1120605182","repostType":4,"repost":{"id":"1120605182","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1638365714,"share":"https://www.laohu8.com/m/news/1120605182?lang=&edition=full","pubTime":"2021-12-01 21:35","market":"us","language":"en","title":"10 Biggest Price Target Changes For Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1120605182","media":"Benzinga","summary":"Morgan Stanley boosted Zscaler, Inc. price target from $275 to $330. Zscaler shares rose 7.1% to $37","content":"<ul>\n <li>Morgan Stanley boosted&nbsp;<b>Zscaler, Inc.</b>&nbsp;price target from $275 to $330. Zscaler shares rose 7.1% to $371.50 in pre-market trading.</li>\n <li>Citigroup boosted&nbsp;<b>Applied Materials, Inc.</b>&nbsp;price target from $160 to $175. Applied Materials shares rose 1.9% to $150.00 in pre-market trading.</li>\n <li>Goldman Sachs cut the price target on&nbsp;<b>TG Therapeutics, Inc.</b>&nbsp;from $26 to $13. TG Therapeutics shares fell 5.3% to $14.40 in pre-market trading.</li>\n <li>Wells Fargo boosted the price target for&nbsp;<b>Ambarella, Inc.</b>&nbsp;from $115 to $185. Ambarella shares jumped 16.4% to $208.90 in pre-market trading.</li>\n <li>Barclays cut&nbsp;<b>Sigilon Therapeutics, Inc.</b>&nbsp;price target from $16 to $7. Sigilon Therapeutics shares fell 0.3% to close at $3.76 on Tuesday.</li>\n <li>Credit Suisse lifted the price target on&nbsp;<b>GLOBALFOUNDRIES Inc.</b>&nbsp;from $75 to $80. GLOBALFOUNDRIES shares rose 3.3% to $71.50 in pre-market trading.</li>\n <li>DA Davidson raised&nbsp;<b>Helen of Troy Limited</b>&nbsp;price target from $254 to $266. Helen of Troy shares fell 2.3% to close at $240.50 on Tuesday.</li>\n <li>Jefferies lifted&nbsp;<b>ImmunoGen, Inc.</b>&nbsp;price target from $7 to $12. ImmunoGen shares fell 3.6% to $5.95 pre-market trading.</li>\n <li>Susquehanna raised the price target on&nbsp;<b>NetApp, Inc.</b>&nbsp;from $100 to $105. NetApp shares rose 1.4% to $90.11 in pre-market trading.</li>\n <li>Truist Securities boosted the price target for&nbsp;<b>Salesforce.com, inc.</b>&nbsp;from $315 to $330. salesforce.com shares fell 6.5% to $266.40 in pre-market trading.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-01 21:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Morgan Stanley boosted&nbsp;<b>Zscaler, Inc.</b>&nbsp;price target from $275 to $330. Zscaler shares rose 7.1% to $371.50 in pre-market trading.</li>\n <li>Citigroup boosted&nbsp;<b>Applied Materials, Inc.</b>&nbsp;price target from $160 to $175. Applied Materials shares rose 1.9% to $150.00 in pre-market trading.</li>\n <li>Goldman Sachs cut the price target on&nbsp;<b>TG Therapeutics, Inc.</b>&nbsp;from $26 to $13. TG Therapeutics shares fell 5.3% to $14.40 in pre-market trading.</li>\n <li>Wells Fargo boosted the price target for&nbsp;<b>Ambarella, Inc.</b>&nbsp;from $115 to $185. Ambarella shares jumped 16.4% to $208.90 in pre-market trading.</li>\n <li>Barclays cut&nbsp;<b>Sigilon Therapeutics, Inc.</b>&nbsp;price target from $16 to $7. Sigilon Therapeutics shares fell 0.3% to close at $3.76 on Tuesday.</li>\n <li>Credit Suisse lifted the price target on&nbsp;<b>GLOBALFOUNDRIES Inc.</b>&nbsp;from $75 to $80. GLOBALFOUNDRIES shares rose 3.3% to $71.50 in pre-market trading.</li>\n <li>DA Davidson raised&nbsp;<b>Helen of Troy Limited</b>&nbsp;price target from $254 to $266. Helen of Troy shares fell 2.3% to close at $240.50 on Tuesday.</li>\n <li>Jefferies lifted&nbsp;<b>ImmunoGen, Inc.</b>&nbsp;price target from $7 to $12. ImmunoGen shares fell 3.6% to $5.95 pre-market trading.</li>\n <li>Susquehanna raised the price target on&nbsp;<b>NetApp, Inc.</b>&nbsp;from $100 to $105. NetApp shares rose 1.4% to $90.11 in pre-market trading.</li>\n <li>Truist Securities boosted the price target for&nbsp;<b>Salesforce.com, inc.</b>&nbsp;from $315 to $330. salesforce.com shares fell 6.5% to $266.40 in pre-market trading.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HELE":"海伦特洛伊家电","GFS":"GLOBALFOUNDRIES Inc.","AMAT":"应用材料","SGTX":"Sigilon Therapeutics, Inc.","CRM":"赛富时","TGTX":"TG Therapeutics Inc.","NTAP":"美国网存","AMBA":"安霸","IMGN":"ImmunoGen","ZS":"Zscaler Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120605182","content_text":"Morgan Stanley boosted Zscaler, Inc. price target from $275 to $330. Zscaler shares rose 7.1% to $371.50 in pre-market trading.\nCitigroup boosted Applied Materials, Inc. price target from $160 to $175. Applied Materials shares rose 1.9% to $150.00 in pre-market trading.\nGoldman Sachs cut the price target on TG Therapeutics, Inc. from $26 to $13. TG Therapeutics shares fell 5.3% to $14.40 in pre-market trading.\nWells Fargo boosted the price target for Ambarella, Inc. from $115 to $185. Ambarella shares jumped 16.4% to $208.90 in pre-market trading.\nBarclays cut Sigilon Therapeutics, Inc. price target from $16 to $7. Sigilon Therapeutics shares fell 0.3% to close at $3.76 on Tuesday.\nCredit Suisse lifted the price target on GLOBALFOUNDRIES Inc. from $75 to $80. GLOBALFOUNDRIES shares rose 3.3% to $71.50 in pre-market trading.\nDA Davidson raised Helen of Troy Limited price target from $254 to $266. Helen of Troy shares fell 2.3% to close at $240.50 on Tuesday.\nJefferies lifted ImmunoGen, Inc. price target from $7 to $12. ImmunoGen shares fell 3.6% to $5.95 pre-market trading.\nSusquehanna raised the price target on NetApp, Inc. from $100 to $105. NetApp shares rose 1.4% to $90.11 in pre-market trading.\nTruist Securities boosted the price target for Salesforce.com, inc. from $315 to $330. salesforce.com shares fell 6.5% to $266.40 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603497394,"gmtCreate":1638437002451,"gmtModify":1638437240940,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603497394","repostId":"1120605182","repostType":4,"isVote":1,"tweetType":1,"viewCount":1185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603016622,"gmtCreate":1638338084779,"gmtModify":1638338084779,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603016622","repostId":"1190156196","repostType":4,"repost":{"id":"1190156196","kind":"news","pubTimestamp":1638242388,"share":"https://www.laohu8.com/m/news/1190156196?lang=&edition=full","pubTime":"2021-11-30 11:19","market":"us","language":"en","title":"5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1190156196","media":"InvestorPlace","summary":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race","content":"<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/537aabc5fd6c7ca4f614ce1b37dc0a75\" tg-width=\"1024\" tg-height=\"576\" width=\"100%\" height=\"auto\"><span>Source: Shutterstock</span></p>\n<p>As Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?</p>\n<p>Investors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.</p>\n<p>While&nbsp;<b>Pfizer’s</b>(NYSE:<b><u>PFE</u></b>)&nbsp;success in&nbsp;producing&nbsp;a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.</p>\n<p>Many vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.</p>\n<ul>\n <li><b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>)</li>\n <li><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>)</li>\n <li><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>)</li>\n <li><b>Johnson &amp; Johnson</b>(NYSE:<b><u>JNJ</u></b>)</li>\n <li><b>Novavax</b>(NASDAQ:<b><u>NVAX</u></b>)</li>\n</ul>\n<p><b>Moderna (MRNA)</b></p>\n<p>Moderna was one of the first companies to have its executive team discuss address the omicron variant.</p>\n<p>On Sunday, CMO Paul Burton spoke to<i>BBC’s</i>Andrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketo<i>CNBC’s</i>“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.</p>\n<p>Bancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.</p>\n<p>This talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.</p>\n<p>While&nbsp;the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p>\n<p>\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p>\n<p>\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p>\n<p><b>Pfizer (PFE)</b></p>\n<p>No pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one&nbsp;<i>InvestorPlace</i>&nbsp;contributorfor CEO of the year.</p>\n<p>The industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.</p>\n<p>Clinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.</p>\n<p>While Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.</p>\n<p>It is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.</p>\n<p><b>BioNTech (BNTX)</b></p>\n<p>Pfizer’s original vaccine partner isn’t missing a beat, either.</p>\n<p>The German biotech innovatortold<i>Business Insider</i>that it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.</p>\n<p>Like its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.</p>\n<p>Like other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,<i>InvestorPlace</i>&nbsp;analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.</p>\n<p><b>Johnson &amp; Johnson (JNJ)</b></p>\n<p>Like its competitors, Johnson &amp; Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”</p>\n<p>Mathai Mammen, global head of research and development at J&amp;J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.</p>\n<p>Mammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.</p>\n<p><b>Novavax (NVAX)</b></p>\n<p>A later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.</p>\n<p>However, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”</p>\n<p>While Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.</p>\n<p>As&nbsp;<i>InvestorPlace</i>&nbsp;Assistant News Writer&nbsp;Eddie Pan&nbsp;reported&nbsp;this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 11:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis ...</p>\n\n<a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","JNJ":"强生","PFE":"辉瑞"},"source_url":"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190156196","content_text":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?\nInvestors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.\nWhile Pfizer’s(NYSE:PFE) success in producing a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.\nMany vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.\n\nModerna(NASDAQ:MRNA)\nPfizer(NYSE:PFE)\nBioNTech (NASDAQ:BNTX)\nJohnson & Johnson(NYSE:JNJ)\nNovavax(NASDAQ:NVAX)\n\nModerna (MRNA)\nModerna was one of the first companies to have its executive team discuss address the omicron variant.\nOn Sunday, CMO Paul Burton spoke toBBC’sAndrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketoCNBC’s“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.\nBancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.\nThis talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.\nWhile the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nPfizer (PFE)\nNo pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one InvestorPlace contributorfor CEO of the year.\nThe industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.\nClinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.\nWhile Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.\nIt is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.\nBioNTech (BNTX)\nPfizer’s original vaccine partner isn’t missing a beat, either.\nThe German biotech innovatortoldBusiness Insiderthat it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.\nLike its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.\nLike other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,InvestorPlace analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.\nJohnson & Johnson (JNJ)\nLike its competitors, Johnson & Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”\nMathai Mammen, global head of research and development at J&J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.\nMammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.\nNovavax (NVAX)\nA later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.\nHowever, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”\nWhile Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.\nAs InvestorPlace Assistant News Writer Eddie Pan reported this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603016147,"gmtCreate":1638338057130,"gmtModify":1638338057130,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603016147","repostId":"1129131439","repostType":4,"repost":{"id":"1129131439","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638285839,"share":"https://www.laohu8.com/m/news/1129131439?lang=&edition=full","pubTime":"2021-11-30 23:23","market":"us","language":"en","title":"Gold and silver stocks  jumped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1129131439","media":"Tiger Newspress","summary":"Gold and silver stocks jumped in morning trading.","content":"<p>Gold and silver stocks jumped in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/02c176526990e689ddfc9f7ffa90e282\" tg-width=\"396\" tg-height=\"657\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/fd1aad69af976f6877e0d77ba4618b6e\" tg-width=\"399\" tg-height=\"301\" referrerpolicy=\"no-referrer\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gold and silver stocks  jumped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGold and silver stocks  jumped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-30 23:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Gold and silver stocks jumped in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/02c176526990e689ddfc9f7ffa90e282\" tg-width=\"396\" tg-height=\"657\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/fd1aad69af976f6877e0d77ba4618b6e\" tg-width=\"399\" tg-height=\"301\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"USAU":"美国黄金公司","GOLD":"巴里克黄金","CDE":"科尔黛伦矿业","PAAS":"泛美白银","AU":"AngloGold Ashanti Ltd ADS","GFI":"金田","HL":"赫克拉矿业","NEM":"纽曼矿业","HMY":"哈莫尼黄金","FSM":"Fortuna Silver Mines Inc","MAG":"MAG银矿","AG":"First Majestic Silver Corporation","KGC":"金罗斯黄金","EXK":"Endeavour Silver","AEM":"伊格尔矿业"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129131439","content_text":"Gold and silver stocks jumped in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1080,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600242226,"gmtCreate":1638164595269,"gmtModify":1638164595269,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600242226","repostId":"1119853738","repostType":4,"repost":{"id":"1119853738","kind":"news","pubTimestamp":1638153494,"share":"https://www.laohu8.com/m/news/1119853738?lang=&edition=full","pubTime":"2021-11-29 10:38","market":"us","language":"en","title":"Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1119853738","media":"Motley Fool","summary":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday","content":"<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.</p>\n<p>While there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.</p>\n<p>How should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers&nbsp;<b>Moderna</b>(NASDAQ:MRNA),<b>Pfizer</b>(NYSE:PFE), and&nbsp;<b>Novavax</b>(NASDAQ:NVAX)&nbsp;all&nbsp;vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.</p>\n<p>The pandemic's latest twist makes these three stocks screaming buys</p>\n<p>Moderna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.</p>\n<p>Pfizer, for its part, said that its&nbsp;<b>BioNTech</b>-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.</p>\n<p>Why are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.</p>\n<p>While Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.</p>\n<p>On the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have&nbsp;dipped in the back half of 2021&nbsp;in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.</p>\n<p>What's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.</p>\n<p>In short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer, and Novavax Are Must-Own Stocks This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 10:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119853738","content_text":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.\nWhile there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.\nHow should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers Moderna(NASDAQ:MRNA),Pfizer(NYSE:PFE), and Novavax(NASDAQ:NVAX) all vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.\nThe pandemic's latest twist makes these three stocks screaming buys\nModerna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.\nPfizer, for its part, said that its BioNTech-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.\nWhy are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.\nWhile Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.\nOn the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have dipped in the back half of 2021 in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.\nWhat's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.\nIn short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600380126,"gmtCreate":1638067132180,"gmtModify":1638067132280,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600380126","repostId":"2186334897","repostType":4,"repost":{"id":"2186334897","kind":"highlight","pubTimestamp":1637936520,"share":"https://www.laohu8.com/m/news/2186334897?lang=&edition=full","pubTime":"2021-11-26 22:22","market":"us","language":"en","title":"Prediction: These 2 Stocks Will Soar in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2186334897","media":"Motley Fool","summary":"These two stocks were battered in 2021, but 2022 could be a different story.","content":"<p>The stock market has been performing amazingly well in 2021. The <b>SPDR S&amp;P 500 ETF</b>&nbsp;has been at or near an all-time high all year, with its biggest drop being in October when it fell 5%.&nbsp;But not all stocks have followed a similar path. Some have fallen up to 70% off their all-time highs. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> of the biggest names that got crushed in 2021 were <b>Pinterest</b> (NYSE:PINS) and <b>Lemonade</b> (NYSE:LMND) -- falling 52% and 72% off their highs, respectively.</p>\n<p>Despite their falls, both companies have strong potential and made substantial business progress while their stocks were pounded. This progress might pay off in 2022, which could send their stocks up to all-time highs.</p>\n<h2>1. Pinterest is not an MAU story</h2>\n<p>Shares of the social media company have gotten hammered in 2021, slowly falling from the highs they hit in the first few months of the year. The company was up against tough 2020 comparables in its earnings reports. The use of Pinterest rose drastically during the COVID-19 pandemic, but as the world slowly reopened, the company saw slower growth internationally and even a decreasing user count in the U.S.</p>\n<p>In Q3 2020, for example, Pinterest has 98 million U.S. monthly active users (MAUs), but that decreased to 89 million in Q3 2021. In Q4 2020, Pinterest saw international MAU grow by 46%, compared to Q3 2021 growth of just 4%.</p>\n<p>While many investors worry about this declining growth, this isn't the primary key to success for Pinterest. The real opportunity for Pinterest is in the increased monetization of its MAUs. Pinterest has plenty of room for expansion of its average revenue per user (ARPU), especially when its ARPU of $1.41 is compared to other social media stocks. <b>Snapchat</b> (NYSE:SNAP) has an ARPU of $3.49, and <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b>' (NASDAQ:FB) ARPU is a whopping $10.</p>\n<p>The company has made important strides during 2021 to increase this monetization. One of those was Pinterest TV -- where creators can sell products from a video -- as well as efforts to make it easier for users to add items to a cart to buy later.</p>\n<p>This increased effort makes advertising on Pinterest more valuable to advertisers, and if these efforts are effective at increasing its ARPU in 2022, investors could see accelerating revenue growth. Currently, the company is growing ARPU at 37% year over year, but the company has the potential to hasten this growth. If the improved efforts are successful, Pinterest could experience significant revenue growth, which could finally make Pinterest a favorable investment again in 2022 and send shares soaring.</p>\n<h2>2. Lemonade's future is bright despite current losses</h2>\n<p>Like Pinterest, shares of the AI-based insurance company have been hammered in 2021. Almost six months after its initial public offering (IPO) in July 2020, the company saw shares skyrocket, jumping over 120% by the start of 2021. However, the hype of the IPO faded, and a tough first quarter due to the Texas freeze (failures in the natural gas infrastructure system that nearly halved the state's gas production) started a downturn that resulted in shares falling 71% off its all-time high.</p>\n<p>The Texas freeze hit Lemonade's net loss ratio, which shows how much the company has to pay in claims for how much it earns in premiums. In Q1, Lemonade's loss ratio reached 121%, meaning that the company paid out significantly more than the money it made in claims (not the best business model). Since Q1, its net loss has decreased, but it is still higher than what the company is aiming for. In Q3, the company's loss ratio was 77%, but the company says its loss ratio should be under 75% in the long term.</p>\n<p>Part of the reason the loss ratio was above 75% in Q3 was because of the rollout of its newer products, like car and pet insurance. The AI for Lemonade's newer products is still being fine-tuned, which is currently resulting in a higher net loss ratio for those products. Yet, despite the loss ratios being high, they are improving rapidly. The pet loss ratio improved by 4 percentage points sequentially, while the homeowners' loss ratio improved by 52 percentage points year over year.</p>\n<p>Clearly, there are trends showing that Lemonade's AI is getting more accurate with its newer products. And as these products mature and the AI gets more precise, investors will likely see these loss ratios improve substantially. The loss ratio has the potential to fall below the 75% threshold, which could help Lemonade rise again and turn investor sentiment positively toward the company.</p>\n<p>The bottom line for both companies is that investors fell out of love with them. Since the reasons they lost hype do not fully represent the company's success, the tide could turn in 2022. If each company's investments into its business in 2021 pay off, today might be a nice buying opportunity to reap benefits going into the new year.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Prediction: These 2 Stocks Will Soar in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPrediction: These 2 Stocks Will Soar in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 22:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/26/prediction-these-two-stocks-will-soar-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market has been performing amazingly well in 2021. The SPDR S&P 500 ETF has been at or near an all-time high all year, with its biggest drop being in October when it fell 5%. But not all ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/26/prediction-these-two-stocks-will-soar-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4550":"红杉资本持仓","BK4549":"软银资本持仓","BK4548":"巴美列捷福持仓","BK4107":"财产与意外伤害保险","BK4554":"元宇宙及AR概念","BK4553":"喜马拉雅资本持仓","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","LMND":"Lemonade, Inc.","BK4566":"资本集团","BK4525":"远程办公概念","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BK4508":"社交媒体","BK4527":"明星科技股","BK4077":"互动媒体与服务","PINS":"Pinterest, Inc."},"source_url":"https://www.fool.com/investing/2021/11/26/prediction-these-two-stocks-will-soar-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186334897","content_text":"The stock market has been performing amazingly well in 2021. The SPDR S&P 500 ETF has been at or near an all-time high all year, with its biggest drop being in October when it fell 5%. But not all stocks have followed a similar path. Some have fallen up to 70% off their all-time highs. Two of the biggest names that got crushed in 2021 were Pinterest (NYSE:PINS) and Lemonade (NYSE:LMND) -- falling 52% and 72% off their highs, respectively.\nDespite their falls, both companies have strong potential and made substantial business progress while their stocks were pounded. This progress might pay off in 2022, which could send their stocks up to all-time highs.\n1. Pinterest is not an MAU story\nShares of the social media company have gotten hammered in 2021, slowly falling from the highs they hit in the first few months of the year. The company was up against tough 2020 comparables in its earnings reports. The use of Pinterest rose drastically during the COVID-19 pandemic, but as the world slowly reopened, the company saw slower growth internationally and even a decreasing user count in the U.S.\nIn Q3 2020, for example, Pinterest has 98 million U.S. monthly active users (MAUs), but that decreased to 89 million in Q3 2021. In Q4 2020, Pinterest saw international MAU grow by 46%, compared to Q3 2021 growth of just 4%.\nWhile many investors worry about this declining growth, this isn't the primary key to success for Pinterest. The real opportunity for Pinterest is in the increased monetization of its MAUs. Pinterest has plenty of room for expansion of its average revenue per user (ARPU), especially when its ARPU of $1.41 is compared to other social media stocks. Snapchat (NYSE:SNAP) has an ARPU of $3.49, and Meta Platforms' (NASDAQ:FB) ARPU is a whopping $10.\nThe company has made important strides during 2021 to increase this monetization. One of those was Pinterest TV -- where creators can sell products from a video -- as well as efforts to make it easier for users to add items to a cart to buy later.\nThis increased effort makes advertising on Pinterest more valuable to advertisers, and if these efforts are effective at increasing its ARPU in 2022, investors could see accelerating revenue growth. Currently, the company is growing ARPU at 37% year over year, but the company has the potential to hasten this growth. If the improved efforts are successful, Pinterest could experience significant revenue growth, which could finally make Pinterest a favorable investment again in 2022 and send shares soaring.\n2. Lemonade's future is bright despite current losses\nLike Pinterest, shares of the AI-based insurance company have been hammered in 2021. Almost six months after its initial public offering (IPO) in July 2020, the company saw shares skyrocket, jumping over 120% by the start of 2021. However, the hype of the IPO faded, and a tough first quarter due to the Texas freeze (failures in the natural gas infrastructure system that nearly halved the state's gas production) started a downturn that resulted in shares falling 71% off its all-time high.\nThe Texas freeze hit Lemonade's net loss ratio, which shows how much the company has to pay in claims for how much it earns in premiums. In Q1, Lemonade's loss ratio reached 121%, meaning that the company paid out significantly more than the money it made in claims (not the best business model). Since Q1, its net loss has decreased, but it is still higher than what the company is aiming for. In Q3, the company's loss ratio was 77%, but the company says its loss ratio should be under 75% in the long term.\nPart of the reason the loss ratio was above 75% in Q3 was because of the rollout of its newer products, like car and pet insurance. The AI for Lemonade's newer products is still being fine-tuned, which is currently resulting in a higher net loss ratio for those products. Yet, despite the loss ratios being high, they are improving rapidly. The pet loss ratio improved by 4 percentage points sequentially, while the homeowners' loss ratio improved by 52 percentage points year over year.\nClearly, there are trends showing that Lemonade's AI is getting more accurate with its newer products. And as these products mature and the AI gets more precise, investors will likely see these loss ratios improve substantially. The loss ratio has the potential to fall below the 75% threshold, which could help Lemonade rise again and turn investor sentiment positively toward the company.\nThe bottom line for both companies is that investors fell out of love with them. Since the reasons they lost hype do not fully represent the company's success, the tide could turn in 2022. If each company's investments into its business in 2021 pay off, today might be a nice buying opportunity to reap benefits going into the new year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874153035,"gmtCreate":1637746892421,"gmtModify":1637746892421,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"Happy Thanksgiving!","listText":"Happy Thanksgiving!","text":"Happy Thanksgiving!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874153035","repostId":"1151702113","repostType":4,"isVote":1,"tweetType":1,"viewCount":397,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":699731988,"gmtCreate":1639890328741,"gmtModify":1639890328871,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699731988","repostId":"2192035909","repostType":4,"isVote":1,"tweetType":1,"viewCount":1498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601261439,"gmtCreate":1638536050441,"gmtModify":1638536050529,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601261439","repostId":"2188540330","repostType":4,"repost":{"id":"2188540330","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1638524158,"share":"https://www.laohu8.com/m/news/2188540330?lang=&edition=full","pubTime":"2021-12-03 17:35","market":"us","language":"en","title":"5 Stocks To Watch For December 3, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2188540330","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\tWall Street expects  Big Lots, Inc.  (NYSE: BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading.\n","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Big Lots, Inc.</b>&nbsp;(NYSE:BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading&nbsp;Thursday.</li>\n <li><b>DiDi Global Inc.</b>&nbsp;(NYSE:DIDI) said that its board of directors had authorized the company to initiate procedures to delist the company’s shares from the New York Stock Exchange. The company, however, announced plans to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange. DiDi Global shares jumped 9.5% to $8.54 in premarket trading&nbsp;Friday.</li>\n <li>Analysts are expecting&nbsp;<b>Hibbett, Inc.</b>&nbsp;(NASDAQ:HIBB) to have earned $1.57 per share on revenue of $360.63 million for the latest quarter. The company will release earnings before the markets open. Hibbett shares rose 0.3% to $72.35 in after-hours trading&nbsp;Thursday.</li>\n</ul>\n<ul>\n <li><b>Tesla Inc</b> (NASDAQ:TSLA) Elon Musk sold another 934,091 shares worth around $1.01 billion in order to fulfill his tax obligations, as per filings made with the U.S. Securities And Exchange Commission Thursday. Musk also exercised options to purchase 2.1 million shares of the automaker at $6.24, as per one of the filings. In late November, the company’s CEO had sold $1 billion worth of Tesla shares. Tesla shares rose 0.3% to $1,088 in premarket tradingFriday.</li>\n <li><b>Ulta Beauty, Inc.</b> (NASDAQ:ULTA) reported better-than-expected results for its third quarter and raised its FY21 forecast. Ulta Beauty shares climbed 5.2% to $403.50 in the after-hours trading Thursday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For December 3, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For December 3, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-03 17:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Big Lots, Inc.</b>&nbsp;(NYSE:BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading&nbsp;Thursday.</li>\n <li><b>DiDi Global Inc.</b>&nbsp;(NYSE:DIDI) said that its board of directors had authorized the company to initiate procedures to delist the company’s shares from the New York Stock Exchange. The company, however, announced plans to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange. DiDi Global shares jumped 9.5% to $8.54 in premarket trading&nbsp;Friday.</li>\n <li>Analysts are expecting&nbsp;<b>Hibbett, Inc.</b>&nbsp;(NASDAQ:HIBB) to have earned $1.57 per share on revenue of $360.63 million for the latest quarter. The company will release earnings before the markets open. Hibbett shares rose 0.3% to $72.35 in after-hours trading&nbsp;Thursday.</li>\n</ul>\n<ul>\n <li><b>Tesla Inc</b> (NASDAQ:TSLA) Elon Musk sold another 934,091 shares worth around $1.01 billion in order to fulfill his tax obligations, as per filings made with the U.S. Securities And Exchange Commission Thursday. Musk also exercised options to purchase 2.1 million shares of the automaker at $6.24, as per one of the filings. In late November, the company’s CEO had sold $1 billion worth of Tesla shares. Tesla shares rose 0.3% to $1,088 in premarket tradingFriday.</li>\n <li><b>Ulta Beauty, Inc.</b> (NASDAQ:ULTA) reported better-than-expected results for its third quarter and raised its FY21 forecast. Ulta Beauty shares climbed 5.2% to $403.50 in the after-hours trading Thursday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4561":"索罗斯持仓","BK4505":"高瓴资本持仓","TSLA":"特斯拉","BK4539":"次新股","CEO":"中海油","DIDI":"滴滴(已退市)","BIG":"必乐透","ULTA":"Ulta美容","BK4526":"热门中概股","BK4200":"专卖店","BK4114":"综合货品商店","HIBB":"希贝特体育","BK4535":"淡马锡持仓","BK4022":"陆运"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188540330","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Big Lots, Inc. (NYSE:BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading Thursday.\nDiDi Global Inc. (NYSE:DIDI) said that its board of directors had authorized the company to initiate procedures to delist the company’s shares from the New York Stock Exchange. The company, however, announced plans to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange. DiDi Global shares jumped 9.5% to $8.54 in premarket trading Friday.\nAnalysts are expecting Hibbett, Inc. (NASDAQ:HIBB) to have earned $1.57 per share on revenue of $360.63 million for the latest quarter. The company will release earnings before the markets open. Hibbett shares rose 0.3% to $72.35 in after-hours trading Thursday.\n\n\nTesla Inc (NASDAQ:TSLA) Elon Musk sold another 934,091 shares worth around $1.01 billion in order to fulfill his tax obligations, as per filings made with the U.S. Securities And Exchange Commission Thursday. Musk also exercised options to purchase 2.1 million shares of the automaker at $6.24, as per one of the filings. In late November, the company’s CEO had sold $1 billion worth of Tesla shares. Tesla shares rose 0.3% to $1,088 in premarket tradingFriday.\nUlta Beauty, Inc. (NASDAQ:ULTA) reported better-than-expected results for its third quarter and raised its FY21 forecast. Ulta Beauty shares climbed 5.2% to $403.50 in the after-hours trading Thursday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1796,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600242226,"gmtCreate":1638164595269,"gmtModify":1638164595269,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600242226","repostId":"1119853738","repostType":4,"repost":{"id":"1119853738","kind":"news","pubTimestamp":1638153494,"share":"https://www.laohu8.com/m/news/1119853738?lang=&edition=full","pubTime":"2021-11-29 10:38","market":"us","language":"en","title":"Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1119853738","media":"Motley Fool","summary":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday","content":"<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.</p>\n<p>While there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.</p>\n<p>How should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers&nbsp;<b>Moderna</b>(NASDAQ:MRNA),<b>Pfizer</b>(NYSE:PFE), and&nbsp;<b>Novavax</b>(NASDAQ:NVAX)&nbsp;all&nbsp;vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.</p>\n<p>The pandemic's latest twist makes these three stocks screaming buys</p>\n<p>Moderna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.</p>\n<p>Pfizer, for its part, said that its&nbsp;<b>BioNTech</b>-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.</p>\n<p>Why are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.</p>\n<p>While Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.</p>\n<p>On the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have&nbsp;dipped in the back half of 2021&nbsp;in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.</p>\n<p>What's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.</p>\n<p>In short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer, and Novavax Are Must-Own Stocks This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 10:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119853738","content_text":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.\nWhile there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.\nHow should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers Moderna(NASDAQ:MRNA),Pfizer(NYSE:PFE), and Novavax(NASDAQ:NVAX) all vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.\nThe pandemic's latest twist makes these three stocks screaming buys\nModerna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.\nPfizer, for its part, said that its BioNTech-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.\nWhy are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.\nWhile Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.\nOn the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have dipped in the back half of 2021 in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.\nWhat's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.\nIn short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696418072,"gmtCreate":1640745844616,"gmtModify":1640745844757,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696418072","repostId":"1186633322","repostType":4,"repost":{"id":"1186633322","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640732718,"share":"https://www.laohu8.com/m/news/1186633322?lang=&edition=full","pubTime":"2021-12-29 07:05","market":"us","language":"en","title":"S&P 500 Ends Lower after Four-Day Rally to Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1186633322","media":"Reuters","summary":"Dec 28  - The S&P 500closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.The Centers for Disease Control and Prevention  on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.The update follows approvals for new pills and more vaccines to fight COVID-19. It hel","content":"<p>Dec 28 (Reuters) - The S&amp;P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.</p>\n<p>The Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.</p>\n<p>The update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc(AAPL.O)shutting its <a href=\"https://laohu8.com/S/NWY\">New York</a> stores due to surging cases, and put U.S. stocks on pace for monthly gains.</p>\n<p>\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in <a href=\"https://laohu8.com/S/NYRT\">New York</a>.</p>\n<p>Seven&nbsp;of the 11 major S&amp;P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and <a href=\"https://laohu8.com/S/JCS\">Communications</a> Services(.SPLRCL)led declines.</p>\n<p>The Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&amp;P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.</p>\n<p>In company news, <a href=\"https://laohu8.com/S/BA\">Boeing</a> Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the aircraft and loss of all 189 people on board.</p>\n<p>Markets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&amp;P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.</p>\n<p>\"<a href=\"https://laohu8.com/S/ISBC\">Investors</a> are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.</p>\n<p>The Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5</p>\n<p>Volume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 Ends Lower after Four-Day Rally to Record High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 Ends Lower after Four-Day Rally to Record High\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-29 07:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 28 (Reuters) - The S&amp;P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.</p>\n<p>The Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.</p>\n<p>The update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc(AAPL.O)shutting its <a href=\"https://laohu8.com/S/NWY\">New York</a> stores due to surging cases, and put U.S. stocks on pace for monthly gains.</p>\n<p>\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in <a href=\"https://laohu8.com/S/NYRT\">New York</a>.</p>\n<p>Seven&nbsp;of the 11 major S&amp;P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and <a href=\"https://laohu8.com/S/JCS\">Communications</a> Services(.SPLRCL)led declines.</p>\n<p>The Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&amp;P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.</p>\n<p>In company news, <a href=\"https://laohu8.com/S/BA\">Boeing</a> Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the aircraft and loss of all 189 people on board.</p>\n<p>Markets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&amp;P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.</p>\n<p>\"<a href=\"https://laohu8.com/S/ISBC\">Investors</a> are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.</p>\n<p>The Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5</p>\n<p>Volume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","UPRO":"三倍做多标普500ETF","SSO":"两倍做多标普500ETF","SDS":"两倍做空标普500ETF","IVV":"标普500指数ETF","SH":"标普500反向ETF","BK4534":"瑞士信贷持仓","OEF":"标普100指数ETF-iShares",".SPX":"S&P 500 Index","SPY":"标普500ETF","SPXU":"三倍做空标普500ETF","BK4504":"桥水持仓","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","OEX":"标普100"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186633322","content_text":"Dec 28 (Reuters) - The S&P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.\nThe Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.\nThe update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and Apple Inc(AAPL.O)shutting its New York stores due to surging cases, and put U.S. stocks on pace for monthly gains.\n\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in New York.\nSeven of the 11 major S&P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and Communications Services(.SPLRCL)led declines.\nThe Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the Nasdaq Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.\nIn company news, Boeing Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of one of the aircraft and loss of all 189 people on board.\nMarkets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.\n\"Investors are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.\nThe Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5\nVolume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.\nThe S&P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605979131,"gmtCreate":1639106306823,"gmtModify":1639106602213,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605979131","repostId":"1144028780","repostType":4,"isVote":1,"tweetType":1,"viewCount":1042,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874153035,"gmtCreate":1637746892421,"gmtModify":1637746892421,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"Happy Thanksgiving!","listText":"Happy Thanksgiving!","text":"Happy Thanksgiving!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874153035","repostId":"1151702113","repostType":4,"repost":{"id":"1151702113","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637559387,"share":"https://www.laohu8.com/m/news/1151702113?lang=&edition=full","pubTime":"2021-11-22 13:36","market":"us","language":"en","title":"Reminder: U.S. stocks will be closed on Thursday for Thanksgiving day,and close three hours earlier on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151702113","media":"Tiger Newspress","summary":"November 25th (this Thursday) is Thanksgiving Day.All financial markets in the United States, includ","content":"<p>November 25th&nbsp;(this&nbsp;Thursday) is Thanksgiving Day.All financial markets in the United States, including U.S. stocks, will be closed for one day.</p>\n<p>On November 26th(this Friday), the Nasdaq and New York Stock Exchange end trading at&nbsp;U.S.&nbsp;Eastern Time&nbsp;1 p.m.(Beijing time/SGT&nbsp;2 am on Saturday),and the trading hours will be 22:30 Beijing time-2:00 the next day.So it will be 3 hours ahead of the regular closing time.</p>\n<p>Stocks&nbsp;in&nbsp;China,Britain, Australia&nbsp;and Singapore&nbsp;will&nbsp;trade as usual.</p>\n<p><b>Background</b></p>\n<p>Thanksgiving&nbsp;Day&nbsp;is a national&nbsp;holiday&nbsp;celebrated on various dates in the United States, Canada, Grenada, Saint Lucia, and Liberia. It began as a day of giving thanks and sacrifice for the blessing of the&nbsp;harvest&nbsp;and of the preceding year. Similarly named festival holidays occur in Germany and Japan. Thanksgiving&nbsp;Day&nbsp;is celebrated on the&nbsp;second Monday of October&nbsp;in Canada and on the&nbsp;fourth Thursday of November&nbsp;in the United States and around the same part of the year in other places.&nbsp;</p>\n<p>Black Friday&nbsp;is a colloquial term for the Friday following&nbsp;Thanksgiving Day in the United States. Many stores offer highly promoted sales at discounted prices and often open very early, sometimes as early as midnight&nbsp;or even on Thanksgiving Day.</p>\n<p><img src=\"https://static.tigerbbs.com/af950d731994581f416aa413e17585d3\" tg-width=\"450\" tg-height=\"281\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Reminder: U.S. stocks will be closed on Thursday for Thanksgiving day,and close three hours earlier on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReminder: U.S. stocks will be closed on Thursday for Thanksgiving day,and close three hours earlier on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-22 13:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>November 25th&nbsp;(this&nbsp;Thursday) is Thanksgiving Day.All financial markets in the United States, including U.S. stocks, will be closed for one day.</p>\n<p>On November 26th(this Friday), the Nasdaq and New York Stock Exchange end trading at&nbsp;U.S.&nbsp;Eastern Time&nbsp;1 p.m.(Beijing time/SGT&nbsp;2 am on Saturday),and the trading hours will be 22:30 Beijing time-2:00 the next day.So it will be 3 hours ahead of the regular closing time.</p>\n<p>Stocks&nbsp;in&nbsp;China,Britain, Australia&nbsp;and Singapore&nbsp;will&nbsp;trade as usual.</p>\n<p><b>Background</b></p>\n<p>Thanksgiving&nbsp;Day&nbsp;is a national&nbsp;holiday&nbsp;celebrated on various dates in the United States, Canada, Grenada, Saint Lucia, and Liberia. It began as a day of giving thanks and sacrifice for the blessing of the&nbsp;harvest&nbsp;and of the preceding year. Similarly named festival holidays occur in Germany and Japan. Thanksgiving&nbsp;Day&nbsp;is celebrated on the&nbsp;second Monday of October&nbsp;in Canada and on the&nbsp;fourth Thursday of November&nbsp;in the United States and around the same part of the year in other places.&nbsp;</p>\n<p>Black Friday&nbsp;is a colloquial term for the Friday following&nbsp;Thanksgiving Day in the United States. Many stores offer highly promoted sales at discounted prices and often open very early, sometimes as early as midnight&nbsp;or even on Thanksgiving Day.</p>\n<p><img src=\"https://static.tigerbbs.com/af950d731994581f416aa413e17585d3\" tg-width=\"450\" tg-height=\"281\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151702113","content_text":"November 25th (this Thursday) is Thanksgiving Day.All financial markets in the United States, including U.S. stocks, will be closed for one day.\nOn November 26th(this Friday), the Nasdaq and New York Stock Exchange end trading at U.S. Eastern Time 1 p.m.(Beijing time/SGT 2 am on Saturday),and the trading hours will be 22:30 Beijing time-2:00 the next day.So it will be 3 hours ahead of the regular closing time.\nStocks in China,Britain, Australia and Singapore will trade as usual.\nBackground\nThanksgiving Day is a national holiday celebrated on various dates in the United States, Canada, Grenada, Saint Lucia, and Liberia. It began as a day of giving thanks and sacrifice for the blessing of the harvest and of the preceding year. Similarly named festival holidays occur in Germany and Japan. Thanksgiving Day is celebrated on the second Monday of October in Canada and on the fourth Thursday of November in the United States and around the same part of the year in other places. \nBlack Friday is a colloquial term for the Friday following Thanksgiving Day in the United States. Many stores offer highly promoted sales at discounted prices and often open very early, sometimes as early as midnight or even on Thanksgiving Day.","news_type":1},"isVote":1,"tweetType":1,"viewCount":397,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605979970,"gmtCreate":1639106274084,"gmtModify":1639106601602,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605979970","repostId":"1120676537","repostType":4,"isVote":1,"tweetType":1,"viewCount":921,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603016622,"gmtCreate":1638338084779,"gmtModify":1638338084779,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603016622","repostId":"1190156196","repostType":4,"repost":{"id":"1190156196","kind":"news","pubTimestamp":1638242388,"share":"https://www.laohu8.com/m/news/1190156196?lang=&edition=full","pubTime":"2021-11-30 11:19","market":"us","language":"en","title":"5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1190156196","media":"InvestorPlace","summary":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race","content":"<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/537aabc5fd6c7ca4f614ce1b37dc0a75\" tg-width=\"1024\" tg-height=\"576\" width=\"100%\" height=\"auto\"><span>Source: Shutterstock</span></p>\n<p>As Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?</p>\n<p>Investors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.</p>\n<p>While&nbsp;<b>Pfizer’s</b>(NYSE:<b><u>PFE</u></b>)&nbsp;success in&nbsp;producing&nbsp;a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.</p>\n<p>Many vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.</p>\n<ul>\n <li><b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>)</li>\n <li><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>)</li>\n <li><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>)</li>\n <li><b>Johnson &amp; Johnson</b>(NYSE:<b><u>JNJ</u></b>)</li>\n <li><b>Novavax</b>(NASDAQ:<b><u>NVAX</u></b>)</li>\n</ul>\n<p><b>Moderna (MRNA)</b></p>\n<p>Moderna was one of the first companies to have its executive team discuss address the omicron variant.</p>\n<p>On Sunday, CMO Paul Burton spoke to<i>BBC’s</i>Andrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketo<i>CNBC’s</i>“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.</p>\n<p>Bancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.</p>\n<p>This talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.</p>\n<p>While&nbsp;the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p>\n<p>\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p>\n<p>\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p>\n<p><b>Pfizer (PFE)</b></p>\n<p>No pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one&nbsp;<i>InvestorPlace</i>&nbsp;contributorfor CEO of the year.</p>\n<p>The industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.</p>\n<p>Clinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.</p>\n<p>While Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.</p>\n<p>It is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.</p>\n<p><b>BioNTech (BNTX)</b></p>\n<p>Pfizer’s original vaccine partner isn’t missing a beat, either.</p>\n<p>The German biotech innovatortold<i>Business Insider</i>that it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.</p>\n<p>Like its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.</p>\n<p>Like other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,<i>InvestorPlace</i>&nbsp;analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.</p>\n<p><b>Johnson &amp; Johnson (JNJ)</b></p>\n<p>Like its competitors, Johnson &amp; Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”</p>\n<p>Mathai Mammen, global head of research and development at J&amp;J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.</p>\n<p>Mammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.</p>\n<p><b>Novavax (NVAX)</b></p>\n<p>A later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.</p>\n<p>However, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”</p>\n<p>While Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.</p>\n<p>As&nbsp;<i>InvestorPlace</i>&nbsp;Assistant News Writer&nbsp;Eddie Pan&nbsp;reported&nbsp;this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 11:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis ...</p>\n\n<a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","JNJ":"强生","PFE":"辉瑞"},"source_url":"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190156196","content_text":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?\nInvestors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.\nWhile Pfizer’s(NYSE:PFE) success in producing a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.\nMany vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.\n\nModerna(NASDAQ:MRNA)\nPfizer(NYSE:PFE)\nBioNTech (NASDAQ:BNTX)\nJohnson & Johnson(NYSE:JNJ)\nNovavax(NASDAQ:NVAX)\n\nModerna (MRNA)\nModerna was one of the first companies to have its executive team discuss address the omicron variant.\nOn Sunday, CMO Paul Burton spoke toBBC’sAndrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketoCNBC’s“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.\nBancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.\nThis talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.\nWhile the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nPfizer (PFE)\nNo pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one InvestorPlace contributorfor CEO of the year.\nThe industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.\nClinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.\nWhile Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.\nIt is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.\nBioNTech (BNTX)\nPfizer’s original vaccine partner isn’t missing a beat, either.\nThe German biotech innovatortoldBusiness Insiderthat it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.\nLike its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.\nLike other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,InvestorPlace analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.\nJohnson & Johnson (JNJ)\nLike its competitors, Johnson & Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”\nMathai Mammen, global head of research and development at J&J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.\nMammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.\nNovavax (NVAX)\nA later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.\nHowever, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”\nWhile Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.\nAs InvestorPlace Assistant News Writer Eddie Pan reported this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603016147,"gmtCreate":1638338057130,"gmtModify":1638338057130,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603016147","repostId":"1129131439","repostType":4,"isVote":1,"tweetType":1,"viewCount":1080,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600380126,"gmtCreate":1638067132180,"gmtModify":1638067132280,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600380126","repostId":"2186334897","repostType":4,"repost":{"id":"2186334897","kind":"highlight","pubTimestamp":1637936520,"share":"https://www.laohu8.com/m/news/2186334897?lang=&edition=full","pubTime":"2021-11-26 22:22","market":"us","language":"en","title":"Prediction: These 2 Stocks Will Soar in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2186334897","media":"Motley Fool","summary":"These two stocks were battered in 2021, but 2022 could be a different story.","content":"<p>The stock market has been performing amazingly well in 2021. The <b>SPDR S&amp;P 500 ETF</b>&nbsp;has been at or near an all-time high all year, with its biggest drop being in October when it fell 5%.&nbsp;But not all stocks have followed a similar path. Some have fallen up to 70% off their all-time highs. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> of the biggest names that got crushed in 2021 were <b>Pinterest</b> (NYSE:PINS) and <b>Lemonade</b> (NYSE:LMND) -- falling 52% and 72% off their highs, respectively.</p>\n<p>Despite their falls, both companies have strong potential and made substantial business progress while their stocks were pounded. This progress might pay off in 2022, which could send their stocks up to all-time highs.</p>\n<h2>1. Pinterest is not an MAU story</h2>\n<p>Shares of the social media company have gotten hammered in 2021, slowly falling from the highs they hit in the first few months of the year. The company was up against tough 2020 comparables in its earnings reports. The use of Pinterest rose drastically during the COVID-19 pandemic, but as the world slowly reopened, the company saw slower growth internationally and even a decreasing user count in the U.S.</p>\n<p>In Q3 2020, for example, Pinterest has 98 million U.S. monthly active users (MAUs), but that decreased to 89 million in Q3 2021. In Q4 2020, Pinterest saw international MAU grow by 46%, compared to Q3 2021 growth of just 4%.</p>\n<p>While many investors worry about this declining growth, this isn't the primary key to success for Pinterest. The real opportunity for Pinterest is in the increased monetization of its MAUs. Pinterest has plenty of room for expansion of its average revenue per user (ARPU), especially when its ARPU of $1.41 is compared to other social media stocks. <b>Snapchat</b> (NYSE:SNAP) has an ARPU of $3.49, and <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b>' (NASDAQ:FB) ARPU is a whopping $10.</p>\n<p>The company has made important strides during 2021 to increase this monetization. One of those was Pinterest TV -- where creators can sell products from a video -- as well as efforts to make it easier for users to add items to a cart to buy later.</p>\n<p>This increased effort makes advertising on Pinterest more valuable to advertisers, and if these efforts are effective at increasing its ARPU in 2022, investors could see accelerating revenue growth. Currently, the company is growing ARPU at 37% year over year, but the company has the potential to hasten this growth. If the improved efforts are successful, Pinterest could experience significant revenue growth, which could finally make Pinterest a favorable investment again in 2022 and send shares soaring.</p>\n<h2>2. Lemonade's future is bright despite current losses</h2>\n<p>Like Pinterest, shares of the AI-based insurance company have been hammered in 2021. Almost six months after its initial public offering (IPO) in July 2020, the company saw shares skyrocket, jumping over 120% by the start of 2021. However, the hype of the IPO faded, and a tough first quarter due to the Texas freeze (failures in the natural gas infrastructure system that nearly halved the state's gas production) started a downturn that resulted in shares falling 71% off its all-time high.</p>\n<p>The Texas freeze hit Lemonade's net loss ratio, which shows how much the company has to pay in claims for how much it earns in premiums. In Q1, Lemonade's loss ratio reached 121%, meaning that the company paid out significantly more than the money it made in claims (not the best business model). Since Q1, its net loss has decreased, but it is still higher than what the company is aiming for. In Q3, the company's loss ratio was 77%, but the company says its loss ratio should be under 75% in the long term.</p>\n<p>Part of the reason the loss ratio was above 75% in Q3 was because of the rollout of its newer products, like car and pet insurance. The AI for Lemonade's newer products is still being fine-tuned, which is currently resulting in a higher net loss ratio for those products. Yet, despite the loss ratios being high, they are improving rapidly. The pet loss ratio improved by 4 percentage points sequentially, while the homeowners' loss ratio improved by 52 percentage points year over year.</p>\n<p>Clearly, there are trends showing that Lemonade's AI is getting more accurate with its newer products. And as these products mature and the AI gets more precise, investors will likely see these loss ratios improve substantially. The loss ratio has the potential to fall below the 75% threshold, which could help Lemonade rise again and turn investor sentiment positively toward the company.</p>\n<p>The bottom line for both companies is that investors fell out of love with them. Since the reasons they lost hype do not fully represent the company's success, the tide could turn in 2022. If each company's investments into its business in 2021 pay off, today might be a nice buying opportunity to reap benefits going into the new year.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Prediction: These 2 Stocks Will Soar in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPrediction: These 2 Stocks Will Soar in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 22:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/26/prediction-these-two-stocks-will-soar-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market has been performing amazingly well in 2021. The SPDR S&P 500 ETF has been at or near an all-time high all year, with its biggest drop being in October when it fell 5%. But not all ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/26/prediction-these-two-stocks-will-soar-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4550":"红杉资本持仓","BK4549":"软银资本持仓","BK4548":"巴美列捷福持仓","BK4107":"财产与意外伤害保险","BK4554":"元宇宙及AR概念","BK4553":"喜马拉雅资本持仓","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","LMND":"Lemonade, Inc.","BK4566":"资本集团","BK4525":"远程办公概念","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BK4508":"社交媒体","BK4527":"明星科技股","BK4077":"互动媒体与服务","PINS":"Pinterest, Inc."},"source_url":"https://www.fool.com/investing/2021/11/26/prediction-these-two-stocks-will-soar-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186334897","content_text":"The stock market has been performing amazingly well in 2021. The SPDR S&P 500 ETF has been at or near an all-time high all year, with its biggest drop being in October when it fell 5%. But not all stocks have followed a similar path. Some have fallen up to 70% off their all-time highs. Two of the biggest names that got crushed in 2021 were Pinterest (NYSE:PINS) and Lemonade (NYSE:LMND) -- falling 52% and 72% off their highs, respectively.\nDespite their falls, both companies have strong potential and made substantial business progress while their stocks were pounded. This progress might pay off in 2022, which could send their stocks up to all-time highs.\n1. Pinterest is not an MAU story\nShares of the social media company have gotten hammered in 2021, slowly falling from the highs they hit in the first few months of the year. The company was up against tough 2020 comparables in its earnings reports. The use of Pinterest rose drastically during the COVID-19 pandemic, but as the world slowly reopened, the company saw slower growth internationally and even a decreasing user count in the U.S.\nIn Q3 2020, for example, Pinterest has 98 million U.S. monthly active users (MAUs), but that decreased to 89 million in Q3 2021. In Q4 2020, Pinterest saw international MAU grow by 46%, compared to Q3 2021 growth of just 4%.\nWhile many investors worry about this declining growth, this isn't the primary key to success for Pinterest. The real opportunity for Pinterest is in the increased monetization of its MAUs. Pinterest has plenty of room for expansion of its average revenue per user (ARPU), especially when its ARPU of $1.41 is compared to other social media stocks. Snapchat (NYSE:SNAP) has an ARPU of $3.49, and Meta Platforms' (NASDAQ:FB) ARPU is a whopping $10.\nThe company has made important strides during 2021 to increase this monetization. One of those was Pinterest TV -- where creators can sell products from a video -- as well as efforts to make it easier for users to add items to a cart to buy later.\nThis increased effort makes advertising on Pinterest more valuable to advertisers, and if these efforts are effective at increasing its ARPU in 2022, investors could see accelerating revenue growth. Currently, the company is growing ARPU at 37% year over year, but the company has the potential to hasten this growth. If the improved efforts are successful, Pinterest could experience significant revenue growth, which could finally make Pinterest a favorable investment again in 2022 and send shares soaring.\n2. Lemonade's future is bright despite current losses\nLike Pinterest, shares of the AI-based insurance company have been hammered in 2021. Almost six months after its initial public offering (IPO) in July 2020, the company saw shares skyrocket, jumping over 120% by the start of 2021. However, the hype of the IPO faded, and a tough first quarter due to the Texas freeze (failures in the natural gas infrastructure system that nearly halved the state's gas production) started a downturn that resulted in shares falling 71% off its all-time high.\nThe Texas freeze hit Lemonade's net loss ratio, which shows how much the company has to pay in claims for how much it earns in premiums. In Q1, Lemonade's loss ratio reached 121%, meaning that the company paid out significantly more than the money it made in claims (not the best business model). Since Q1, its net loss has decreased, but it is still higher than what the company is aiming for. In Q3, the company's loss ratio was 77%, but the company says its loss ratio should be under 75% in the long term.\nPart of the reason the loss ratio was above 75% in Q3 was because of the rollout of its newer products, like car and pet insurance. The AI for Lemonade's newer products is still being fine-tuned, which is currently resulting in a higher net loss ratio for those products. Yet, despite the loss ratios being high, they are improving rapidly. The pet loss ratio improved by 4 percentage points sequentially, while the homeowners' loss ratio improved by 52 percentage points year over year.\nClearly, there are trends showing that Lemonade's AI is getting more accurate with its newer products. And as these products mature and the AI gets more precise, investors will likely see these loss ratios improve substantially. The loss ratio has the potential to fall below the 75% threshold, which could help Lemonade rise again and turn investor sentiment positively toward the company.\nThe bottom line for both companies is that investors fell out of love with them. Since the reasons they lost hype do not fully represent the company's success, the tide could turn in 2022. If each company's investments into its business in 2021 pay off, today might be a nice buying opportunity to reap benefits going into the new year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603497233,"gmtCreate":1638437025726,"gmtModify":1638437670837,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603497233","repostId":"1120605182","repostType":4,"isVote":1,"tweetType":1,"viewCount":1105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603497394,"gmtCreate":1638437002451,"gmtModify":1638437240940,"author":{"id":"4099622722860440","authorId":"4099622722860440","name":"LiliMe","avatar":"https://static.tigerbbs.com/4202d921353cc8edc625e395870b44a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099622722860440","authorIdStr":"4099622722860440"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603497394","repostId":"1120605182","repostType":4,"isVote":1,"tweetType":1,"viewCount":1185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}